Gian Life Care Ltd
GIANLIFEGian Life Care Ltd
GIANLIFE
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
LowUndervalued compared to the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 5.41 | 1.09 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.53 | 6.56 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Gian Life Care Limited is an India-based company primarily engaged in the business of providing diagnostic and related healthcare tests and services. The Company provides a range of diagnostic and related healthcare tests and services such as patient diagnosis services and prevention and wellness diagnosis services to patients and healthcare providers. The Company is focused on opening several diagnostics labs in various parts of the State. Its customers include individual patients, hospitals, other healthcare providers and corporate customers.
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2022 | FY 2023 | FY 2024 | TTM | ||||
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 16.44 | 12.61 | 13.79 | 13.05 | ||||
Raw Materials | 0.00 | 0.00 | 0.00 | 6.65 | ||||
| Power & Fuel Cost | 0.24 | 0.21 | 0.20 | |||||
| Employee Cost | 1.31 | 1.74 | 0.93 | |||||
| Selling & Administrative Expenses | 3.66 | 3.50 | 2.74 | |||||
| Operating & Other expenses | 4.66 | 4.63 | 3.10 | |||||
EBITDA | 6.57 | 2.53 | 6.82 | 6.40 | ||||
| Depreciation/Amortization | 0.33 | 0.50 | 0.53 | 0.51 | ||||
| PBIT | 6.24 | 2.03 | 6.29 | 5.89 | ||||
| Interest & Other Items | 0.39 | 0.45 | 0.54 | 0.50 | ||||
| PBT | 5.85 | 1.58 | 5.75 | 5.39 | ||||
| Taxes & Other Items | 1.48 | 0.53 | 1.59 | 1.50 | ||||
| Net Income | 4.37 | 1.05 | 4.16 | 3.89 | ||||
| EPS | 4.23 | 1.02 | 4.02 | 3.76 | ||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CareHealth Care Services
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Gian Life Care Ltd | 5.06 | 1.09 | — |
| Family Care Hospitals Ltd | 3.09 | 0.66 | — |
Price Comparison
Compare GIANLIFE with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 1.60%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
GIANLIFE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNet profit of Gian Lifecare declined 40.00% to Rs 0.12 crore in the quarter ended September 2024 as against Rs 0.20 crore during the previous quarter ended September 2023. Sales declined 15.22% to Rs 1.95 crore in the quarter ended September 2024 as against Rs 2.30 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1.952.30 -15 OPM %11.2814.35 - PBDT0.260.37 -30 PBT0.140.24 -42 NP0.120.20 -40 Powered by Capital Market - Live
Gian Lifecare will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Gian Lifecare announced that the 6th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Gian Lifecare will hold a meeting of the Board of Directors of the Company on 23 August 2024.Powered by Capital Market - Live
Net profit of Gian Lifecare declined 65.38% to Rs 0.09 crore in the quarter ended June 2024 as against Rs 0.26 crore during the previous quarter ended June 2023. Sales declined 18.52% to Rs 1.98 crore in the quarter ended June 2024 as against Rs 2.43 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1.982.43 -19 OPM %11.1120.99 - PBDT0.270.53 -49 PBT0.150.40 -63 NP0.090.26 -65 Powered by Capital Market - Live
Gian Lifecare will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 16.48%
High Pledged Promoter Holding
A significant proportion of promoter holdings is pledged